Proxime

Industry: Device for modifying cells

One exciting form of gene therapy works by using a virus to introduce therapeutic DNA into cells, and then administering those cells to the patient. But the process of altering the cells is slow and costly, making the gene therapy costly, too.

Proxime has built a device to make it faster and easier to alter cells with beneficial DNA. The device forces the viral vector and the cells into direct contact by organizing them into a space as thin as a human hair. That means far less of the costly vector is needed.

Proxime’s device can create 1 billion altered cells at a time, six times faster than conventional approaches and with one-fourth the amount of vector. The result will be more accessible, affordable gene therapy. 

Company website: Proxime

Back to companies